Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Data Vision Co's yield on cost for the quarter that ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Medical Data Vision Co's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Medical Data Vision Co's highest Yield on Cost was 1.74. The lowest was 0.10. And the median was 0.79.
TSE:3902's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.91 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Medical Data Vision Co (TSE:3902) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medical Data Vision Co 5-Year Yield-on-Cost % Related Terms
TSE:3902 vs VEEV, TEM, BTSG: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, Medical Data Vision Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's 5-Year Yield-on-Cost % falls into.
Medical Data Vision Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Medical Data Vision Co (TSE:3902) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medical Data Vision Co and its competitors. Over the past decade, Medical Data Vision Co's 5-Year Yield-on-Cost % has ranged from 0.10 to 1.74.
Is Medical Data Vision Co's 5-Year Yield-on-Cost % too high?
Medical Data Vision Co's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 1.74. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's 5-Year Yield-on-Cost % compare to VEEV and TEM?
Medical Data Vision Co's 5-Year Yield-on-Cost % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median 5-Year Yield-on-Cost % is 2.91. Historically, Medical Data Vision Co's own 5-Year Yield-on-Cost % has ranged from 0.10 to 1.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.91, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
5-Year Yield-on-Cost %: 0.00
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
